Democrats Urge Trump To Remove Language About Biologics In Trade Agreement
The lawmakers say the pending language in the U.S.-Mexico-Canada agreement “would hinder Congress from taking action to increase competition and enhance patient access to more affordable medicines.”
Stat:
Lawmakers Urge Trump Administration To Alter Trade Deal Or Americans Will Pay More For Drugs
More than 100 Democratic members of Congress urged the Trump administration to remove pending language from the U.S.-Mexico-Canada Agreement trade agreement that would lock the U.S into at least 10 years of marketing exclusivity for biologics, a move they argue will hurt taxpayers and patients. (Silverman, 7/12)
In other pharmaceutical news —
Reuters:
Democrats Take Aim As Trump Abandons Drug Pricing Plan
Democrats see U.S. President Donald Trump becoming increasingly vulnerable to criticism about healthcare costs after the administration's decision to scrap a proposal to lower drug prices, and 2020 White House candidates are rushing to seize the spotlight on the issue. The debate over the future of the American healthcare system has become a focal point of the Democratic presidential nominating contest. As Trump has failed to make strides to remedy the problem, Democrats are becoming more vocal. (Gibson, 7/13)
